nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A History of Lung Cancer: the recalcitrant disease
|
Ahmed, Merina |
|
2014 |
15 |
7 |
p. 687 |
artikel |
2 |
A near miss for prostate cancer immunotherapy
|
Parker, Chris |
|
2014 |
15 |
7 |
p. 669-671 |
artikel |
3 |
ASTRO supports radiotherapy self-referral report
|
Burki, Talha Khan |
|
2014 |
15 |
7 |
p. e255 |
artikel |
4 |
Baseline standards for paediatric oncology nursing care in low to middle income countries: position statement of the SIOP PODC Nursing Working Group
|
Day, Sara |
|
2014 |
15 |
7 |
p. 681-682 |
artikel |
5 |
Breast cancer in China
|
Fan, Lei |
|
2014 |
15 |
7 |
p. e279-e289 |
artikel |
6 |
Breast cancer in older women: predicting adjuvant benefit
|
Brain, Etienne |
|
2014 |
15 |
7 |
p. 672-674 |
artikel |
7 |
Cancer in refugees in Jordan and Syria between 2009 and 2012: challenges and the way forward in humanitarian emergencies
|
Spiegel, Paul |
|
2014 |
15 |
7 |
p. e290-e297 |
artikel |
8 |
Carboplatin for early triple-negative breast cancer?
|
Valero, Vicente |
|
2014 |
15 |
7 |
p. 676-678 |
artikel |
9 |
Carboplatin plus paclitaxel scheduling for advanced ovarian cancer
|
Baratti, Dario |
|
2014 |
15 |
7 |
p. e249 |
artikel |
10 |
Carboplatin plus paclitaxel scheduling for advanced ovarian cancer
|
Shimokata, Tomoya |
|
2014 |
15 |
7 |
p. e249-e250 |
artikel |
11 |
Carboplatin plus paclitaxel scheduling for advanced ovarian cancer – Authors' reply
|
Pignata, Sandro |
|
2014 |
15 |
7 |
p. e250-e251 |
artikel |
12 |
Classification of endometrial carcinoma: more than two types
|
Murali, Rajmohan |
|
2014 |
15 |
7 |
p. e268-e278 |
artikel |
13 |
Clinical use of dendritic cells for cancer therapy
|
Anguille, Sébastien |
|
2014 |
15 |
7 |
p. e257-e267 |
artikel |
14 |
Correction to Lancet Oncol 2014; 15: 621
|
|
|
2014 |
15 |
7 |
p. e253 |
artikel |
15 |
Correction to Lancet Oncol 2014; 15: 606
|
|
|
2014 |
15 |
7 |
p. e253 |
artikel |
16 |
Correction to Lancet Oncol 2013; 14: 1242
|
|
|
2014 |
15 |
7 |
p. e253 |
artikel |
17 |
Decoding Annie Parker
|
van Dorn, Aaron |
|
2014 |
15 |
7 |
p. 685 |
artikel |
18 |
Drawing Women's Cancer
|
Clague, Stephanie |
|
2014 |
15 |
7 |
p. 685-686 |
artikel |
19 |
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
|
Sartor, Oliver |
|
2014 |
15 |
7 |
p. 738-746 |
artikel |
20 |
18F-FDG PET/CT scans for children and adolescents
|
Lassmann, Michael |
|
2014 |
15 |
7 |
p. e243-e244 |
artikel |
21 |
18F-FDG PET/CT scans for children and adolescents – Authors' reply
|
Daldrup-Link, Heike |
|
2014 |
15 |
7 |
p. e244 |
artikel |
22 |
Full-spectrum colonoscopy for adenoma detection
|
Dawwas, Muhammad F |
|
2014 |
15 |
7 |
p. e244-e245 |
artikel |
23 |
Full-spectrum colonoscopy for adenoma detection – Author reply
|
Gralnek, Ian M |
|
2014 |
15 |
7 |
p. e245-e246 |
artikel |
24 |
Future priorities for the IARC Monographs
|
Straif, Kurt |
|
2014 |
15 |
7 |
p. 683-684 |
artikel |
25 |
HER2-positive breast cancer: a new piece of the puzzle
|
Gnant, Michael |
|
2014 |
15 |
7 |
p. 668-669 |
artikel |
26 |
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
|
Kwon, Eugene D |
|
2014 |
15 |
7 |
p. 700-712 |
artikel |
27 |
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
|
Vitolo, Umberto |
|
2014 |
15 |
7 |
p. 730-737 |
artikel |
28 |
Letermovir: a novel drug for cytomegalovirus prophylaxis
|
Bagcchi, Sanjeet |
|
2014 |
15 |
7 |
p. e256 |
artikel |
29 |
Life, love, and loss: a tale of terminal cancer
|
Gourd, Katherine |
|
2014 |
15 |
7 |
p. 688 |
artikel |
30 |
Lymphoma-directed conditioning for aggressive lymphoma
|
Sureda, Anna |
|
2014 |
15 |
7 |
p. 678-679 |
artikel |
31 |
Minimally-invasive approach for rectal cancer surgery
|
Brouquet, Antoine |
|
2014 |
15 |
7 |
p. 680-681 |
artikel |
32 |
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
|
von Minckwitz, Gunter |
|
2014 |
15 |
7 |
p. 747-756 |
artikel |
33 |
On the Cancer Frontier
|
Burki, Talha Khan |
|
2014 |
15 |
7 |
p. 686-687 |
artikel |
34 |
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial
|
Jeong, Seung-Yong |
|
2014 |
15 |
7 |
p. 767-774 |
artikel |
35 |
Organs from some cancer patients safe for transplantation
|
Tanday, Sanjay |
|
2014 |
15 |
7 |
p. e254 |
artikel |
36 |
Origins research in large cell lymphoma—time for action?
|
Witzig, Thomas E |
|
2014 |
15 |
7 |
p. 674-675 |
artikel |
37 |
PET-CT before colorectal cancer surgery is not beneficial
|
Tanday, Sanjay |
|
2014 |
15 |
7 |
p. e256 |
artikel |
38 |
Plain-packaging challenge and e-cigarette regulation
|
Burki, Talha Khan |
|
2014 |
15 |
7 |
p. e254 |
artikel |
39 |
Play to Cure: Genes in Space
|
Coburn, Cassandra |
|
2014 |
15 |
7 |
p. 688 |
artikel |
40 |
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
|
Gregorc, Vanesa |
|
2014 |
15 |
7 |
p. 713-721 |
artikel |
41 |
Prostate cancer bone metastases: not so systemic after all
|
Logothetis, Christopher J |
|
2014 |
15 |
7 |
p. 675-676 |
artikel |
42 |
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial
|
Glass, Bertram |
|
2014 |
15 |
7 |
p. 757-766 |
artikel |
43 |
Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live?
|
LeBlanc, Thomas |
|
2014 |
15 |
7 |
p. e251-e252 |
artikel |
44 |
Stereotactic radiosurgery for patients with brain metastases
|
Alongi, Filippo |
|
2014 |
15 |
7 |
p. e246-e247 |
artikel |
45 |
Stereotactic radiosurgery for patients with brain metastases
|
Takiguchi, Yuichi |
|
2014 |
15 |
7 |
p. e247-e248 |
artikel |
46 |
Stereotactic radiosurgery for patients with brain metastases – Authors' reply
|
Yamamoto, Masaaki |
|
2014 |
15 |
7 |
p. e248 |
artikel |
47 |
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
|
Krop, Ian E |
|
2014 |
15 |
7 |
p. 689-699 |
artikel |
48 |
UK pharmaceutical industry under threat
|
The Lancet Oncology, |
|
2014 |
15 |
7 |
p. 667 |
artikel |
49 |
Uruguay versus tobacco giant Phillip Morris International
|
Burki, Talha Khan |
|
2014 |
15 |
7 |
p. e255 |
artikel |
50 |
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study
|
de Glas, Nienke A |
|
2014 |
15 |
7 |
p. 722-729 |
artikel |
51 |
VeriStrat validated in patients with non-small-cell lung cancer
|
Butts, Charles A |
|
2014 |
15 |
7 |
p. 671-672 |
artikel |